Acute myocardial infarction in patients under 45 years;Infarto agudo de miocardio en pacientes menores de 45 años

Revista Espanola de Cardiologia

Volumn 55, Issue 11, 2002, Pages 1124-1131

  Morillas, Pedro ^a   Cabadés, Adolfo ^a   Bertomeu, Vicente ^a   Echanove, Ildefonso ^a   Colomina, Francisco ^a   Cebrián, Javier ^a   Pérez, Gloria ^a   Mota, Ángel ^a   Sánchez, Francisco Javier ^a   Sanz, Juan Carlos ^a  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

Author keywords

Myocardial infarction; Registry; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANISTREPLASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HEPARIN; INOTROPIC AGENT; LIDOCAINE; NIFEDIPINE; NITRATE; STREPTOKINASE; UROKINASE; VERAPAMIL;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; BLOOD CLOT LYSIS; CIGARETTE SMOKING; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FREQUENCY ANALYSIS; HEALTH CARE SYSTEM; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PROGNOSIS; REGISTER; TRANSLUMINAL CORONARY ANGIOPLASTY; COMPARATIVE STUDY; HEART INFARCTION; RISK FACTOR;

ADULT; AGE FACTORS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 1842835035     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(02)76774-2     Document Type: Article

References (32)

1. Villar F, Banegas JR, Rodríguez F. Mortalidad por cardiopatía isquémica en España. En: Plaza Pérez I, editor. Cardiología preventiva. Barcelona: Ediciones Doyma, 2000; p. 1-7.
2. Serrano JA. Epidemiología de la cardiopatía isquémica. Factores de riesgo y prevenci primaria. En: Delcán JL, editor. Cardiopatía isquémica. Madrid: ENE ediciones, 1999; p. 15-69.
3. Cabadés A, Echanove I, Cebrián J, Cardona J, Valls F, Parra V, et al. Características, manejo y pronóstico del paciente con infarto agudo de miocardio en la Comunidad Valenciana en 1995: resultados del registro PRIMVAC (Proyecto de Registro de Infarto Agudo de Miocardio de Valencia, Alicante y Castellón). Rev Esp Cardiol 1999;52:123-33.
4. 9 Update. ACC/AHA Guidelines for the management of patients with acute myocardial infarction: executive summary and recomendation. Circulation 1999;100:1016-30.
5. Plan de Salud de la Comunidad Valenciana. 2001-2004. Consellería de Sanitat. Generalitat Valenciana: INE, 2001.
6. Cabadés A, Lopez-Bescos L, Aros F, Loma-Osorio A, Bosch X, Pabon P, et al. Variabilidad en el manejo y pronóstico a corto y medio plazo del infarto de miocardio en España: el estudio PRIAMHO. Rev Esp Cardiol 1999;52:767-75.
7. Choudhury L, Marsh J. Myocardial infarction in young patients. Am J Med 1999;107:254-61.
8. Doughty M, Mehta R, Bruckman D, Das S, Karavite D, Tsai T, et al. Acute myocardial infarction in the young. The University of Michigan experience. Am Heart J 2002;143:56-62.
9. Toyofuku M, Goto Y, Matsumoto I, Miyao Y, Morii I, Daikoku S, et al. Acute myocardial infarction in young japanese women. J Cardiol 1996;28:313-9.
10. Rumbolat Z, Rumbolat M, Presenti S, Polic S, Miric D. Peculiarities of myocardial infarction at young age in Southern Croatia. Cardiologia 1995;40:407-11.
11. Sytkowski PA, D'Agostino RB, Belanger A, Kannel WB. Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study. Am J Epidemiol 1996;143: 338-50.
12. Barbash GI, Whitte HD, Modan M, Diaz R, Hampton JR, Heikkila J, et al. Acute myocardial infarction in the young -the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Eur Heart J 1995;16: 313-6.
13. Hoit BD, Gilpin EA, Henning H, Maisel AA, Dittrich H, Carlisse J, et al. Myocardial infarction in young patients: an analysis by age subsets. Circulation 1986;74:712-21.
14. Fournier JA, Sánchez A, Quero J, Fernández-Cortacero JA, González-Barrero A. Myocardial infarction in men aged 40 years or less, a prospective clinical-angiographic study. Clinical Cardiology 1996;19:631-6.
15. Tanajura LP, Piegas LS, Timerman A, Ramos RF, Gun C, Timerman S, et al. Acute myocardial infarction in patients under 40 years of age. Arq Bras Cardiol 1990;55:237-40.
16. Kanitz MG, Giovannucci SJ, Jones JS, Mott M. Myocardial infarction in young adults: risk factors and clinical features. J Emerg Med 1996;14:137-45.
17. Badui E, Rangel A, Valdespino A, Graef A, Plaza A, Chavez E, et al. Infarto agudo de miocardio en adultos jóvenes. Presentación de 142 casos. Arch Inst Cardiol Mex 1993;63:529-37.
18. Barakat K, Wilkinson P, Deaner A, Fluck D, Ranjadayalan K, Timmis A. How should age affect management of acute myocardial infarction? A prospective cohort study. Lancet 1999; 353:955-9.
19. Arós F, Loma-Osorio A, Bosch X, González Aracil J, López Bescós L, Marrugat J, et al. Manejo del infarto de miocardio en España (1995-1999). Datos del registro de infartos de la Sección de Cardiopatía Isquémica y Unidades Coronarias (RISCI) de la Sociedad Española de Cardiología. Rev Esp Cardiol 2001;54:1033-40.
20. Boersma E, Maas ACP, Deckers JW, Simdons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-5.
21. Gersh B. Current issues in reperfusion therapy. Am J Cardiol 1998;82:3P-11P.
22. Hofgren C, Karlson BW, Herlitz J. Prodromal symptoms in subsets of patients hospitalized for suspected acute myocardial infarction. Heart Lung 1995;24:444-56.
23. French W. Trends in acute myocardial infarction management: use of the national registry of myocardial infarction in quality improvement. Am J Cardiol 2000;85:5-9.
24. Klein H, Hengstenberg CH, Peuckert M, Jurgersen R. Comparaison of death rates from acute myocardial infarction in a single hospital in two different periods (1987-1988 vs 1988-1989). Am J Cardiol 1993;71:518-23.
25. Guadagnoli E, Hauptman PJ, Ayanian JZ, Pashos CL, McNeil BJ, Cleary PD. Variation in the use of cardiac procedures after acute myocardial infarction. N Engl J Med 1995;333:573-8.
26. European Secondary Prevention Study Group. Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction. Lancet 1996;347:1203-7.
27. Yusuf S, Peto R, Lewi J, Collins R, Sleight P. Betablockade during and after myocardial infarction. An overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71.
28. Bertolasi CA, Mauro V. Infarto de miocardio en el anciano. Rev Esp Cardiol 2000;53:1428-31.
29. Cabadés A, Valls F, Echanove I, Frances M, SanJuan R, Calabuig J, et al. Estudio RICVAL: El infarto agudo de miocardio en la ciudad de Valencia. Datos de 1.124 pacientes en los primeros 12 meses del registro (diciembre de 1993-noviembre de 1994). Rev Esp Cardiol 1997;50:383-96.
30. Antman E, Berlin JA. Declining incidence of ventricular fibrillation in myocardial infarction. Circulation 1992;86:764-73.
31. Weaver WD, Litwin PE, Martin JS, Kudenchuk PJ, Maynard C, Eisenberg MS, et al. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction: the MITI Project Group. J Am Coll Cardiol 1991;18:657-62.
32. American Heart Association. Heart and stroke facts: 1996 statistical supplement. Dallas: American Heart Association, 1996; p. 1-23.